Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Review determines effective, safe treatments for female hair loss.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

Hair regrowth slows with age and can be affected by treatments that change enzyme activity in the skin.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Transplant patients often get skin problems, with treatments varying by condition.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Puerariae Flos extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.